Randomized open labelled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer

European Urology

Volumn 30, Issue SUPPL. 1, 1996, Pages 7-14

  Wechsel, H W ^a   Zerbib, M ^a   Pagano, F ^a   Coptcoat, M J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Advanced prostate cancer; GnRH agonist; Leuprorelin acetate 3M depot

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN; LEUPRORELIN; TESTOSTERONE;

ADULT; AGED; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL;

EID: 0029826497     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000474238     Document Type: Conference Paper

References (0)